Work productivity and costs related to patients with ankylosing spondylitis, rheumatic arthritis and psoriasis

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F14%3A%230005087" target="_blank" >RIV/00023728:_____/14:#0005087 - isvavai.cz</a>

Výsledek na webu

<a href="http://www.sciencedirect.com/science/article/pii/S2212109914000624?np=y" target="_blank" >http://www.sciencedirect.com/science/article/pii/S2212109914000624?np=y</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.vhri.2014.07.008" target="_blank" >10.1016/j.vhri.2014.07.008</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Work productivity and costs related to patients with ankylosing spondylitis, rheumatic arthritis and psoriasis

Popis výsledku v původním jazyce

The aim of this research was to determine and compare the impact of rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriasis psoriatic arthritis on work productivity to calculate the productivity costs (PC) according to the Friction cost approach methodology. We also to map out factors that influence (functional status and disease activity) work productivity, which was measured by the Work Productivity and Activity Impairment questionnaire (WPAI). We did not find significant differences in Work Productivity and Activity Impairment domains among various diagnoses. Patients with AS, RA, and psoriasis reported overall work productivity losses of 40.9%, 42.9%, and 42.8%, respectively. Daily activity impairments were approximately 50.0%. Overall work productivity loss strongly correlated with PROs, whereas correlations with clinical parameters were weak. The average annual lost PC per patient was estimated to be euro 2,000

Název v anglickém jazyce

Work productivity and costs related to patients with ankylosing spondylitis, rheumatic arthritis and psoriasis

Popis výsledku anglicky

The aim of this research was to determine and compare the impact of rheumatoid arthritis (RA), ankylosing spondylitis (AS), and psoriasis psoriatic arthritis on work productivity to calculate the productivity costs (PC) according to the Friction cost approach methodology. We also to map out factors that influence (functional status and disease activity) work productivity, which was measured by the Work Productivity and Activity Impairment questionnaire (WPAI). We did not find significant differences in Work Productivity and Activity Impairment domains among various diagnoses. Patients with AS, RA, and psoriasis reported overall work productivity losses of 40.9%, 42.9%, and 42.8%, respectively. Daily activity impairments were approximately 50.0%. Overall work productivity loss strongly correlated with PROs, whereas correlations with clinical parameters were weak. The average annual lost PC per patient was estimated to be euro 2,000

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FE - Ostatní obory vnitřního lékařství

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Value in Health Regional issues 2014; V4c: 100-106

ISSN

2212-1099

e-ISSN

—

Svazek periodika

2014

Číslo periodika v rámci svazku

4c

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

7

Strana od-do

100-106

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—